Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
We aspire to help patients and clinicians confront the most challenging cancers in modern medicine
Kazia’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer, which are poorly served by existing therapies
Click here
to access resources for patients
We work at the cutting edge of scientific innovation to find new approaches to cancer treatment
Kazia’s international team harnesses a detailed understanding of the molecular pathways driving cancer to deliver drug candidates which are first-in-class or best-in-class
Click here
to access resources for researchers
We draw on the best research available, and partner with the world’s leading experts in cancer treatment
Kazia’s unique strength lies in the ability to identify promising undervalued drug candidates around the world, and to collaborate with researchers to discover and develop their potential
Click here
to access resources for partners
News
More News
Media
More Media
Resources
More Resources
Stock Information
Symbol
ASX:
Price
Change
(
)
Volume
Low / High
/
Market Cap
Stock Information
Symbol
NASDAQ:
Price
Change
(
)
Volume
Low / High
/
Market Cap